About AmpliGene India Biotech
AmpliGene India Biotech is a Healthcare company based in Ahmedabad (India) founded in 2012 by Chirag Pandya. Isothermal nucleic acid amplification systems are developed for pathogen detection. Its chief executive, as recorded, is Chirag Pandya. Its Indian entity Ampligene India Biotech Private Limited reported revenue of ₹53.9 Lakh. AmpliGene India Biotech offers products and services including Molecular Technology Platform and GMO Testing Services. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems.
Company details
AmpliGene India Biotech was founded in 2012 in Ahmedabad, India, within the biotechnology sector. Isothermal nucleic acid amplification technologies are developed, focusing on portable point-of-care systems like the Genie II. These systems are applied for detecting plant pathogens and infectious diseases in animals, supporting diagnostics in agricultural and veterinary fields across relevant geographies.
- Headquarters Ahmedabad, India
- Founders Chirag Pandya
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ampligeneindia.com
- Social Facebook Instagram
- Legal Name Ampligene India Biotech Private Limited
- Date of Incorporation 18 Sep, 2012
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹53.9 Lakh
FY 2025 · -24% YoY
- Net Profit₹66,477
FY 2025 · 1% margin
- EBITDA₹5.3 Lakh
FY 2025 · 10% margin
Associated legal entities of AmpliGene India Biotech
AmpliGene India Biotech is associated with 2 registered companies on The Company Check; the primary company is Ampligene India Biotech Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ampligene India Biotech Private Limited CIN U52100GJ2012PTC072019 | Active | 18 Sep 2012 | Ahmedabad, Gujarat | ₹0.5 Cr | 3 | View details | |
| Ampligene Diagnostics Private Limited CIN U93090GJ2018PTC105179 | Active | 14 Nov 2018 | Ahmedabad, Gujarat | ₹0.0 Cr | 2 | View details |
Products & Services of AmpliGene India Biotech
AmpliGene India Biotech offers a comprehensive portfolio of products and services, including Molecular Technology Platform and GMO Testing Services.
Platform standardizing molecular applications for healthcare delivery.
Solutions for detecting GMOs in food and agricultural samples.
Board of directors of Ampligene India Biotech Private Limited (AmpliGene India Biotech)
Ampligene India Biotech Private Limited is the primary company behind AmpliGene India Biotech. The boards of the 2 registered companies of AmpliGene India Biotech currently have 3 directors; the longest-serving is Nirupama Ramkrishna Pandya, appointed in 2012. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nirupama Ramkrishna Pandya DIN 06364760 | Director | 18 Sep 2012 | 14 yrs 1 mo | Ampligene India Biotech Private Limited |
| Deepal Pandya DIN 06444861 | Director | 08 Dec 2012 | 13 yrs 11 mo | Ampligene India Biotech Private Limited, Ampligene Diagnostics Private Limited |
| Chirag Ramkrishna Pandya DIN 06860811 | Director | 17 Jul 2018 | 8 yrs 3 mo | Ampligene India Biotech Private Limited, Ampligene Diagnostics Private Limited |
People of AmpliGene India Biotech
1 people are tracked at AmpliGene India Biotech (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership |
Complete people profiles for AmpliGene India Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of AmpliGene India Biotech
Figures of Ampligene India Biotech Private Limited, the primary company behind AmpliGene India Biotech, for FY 2025. Revenue was ₹53.9 Lakh (-24% year on year). Net profit was ₹66,477 (1% margin). EBITDA was ₹5.3 Lakh (10% margin). Revenue has grown at a compounded annual rate of -43% over three years and -5% over five years.
- ₹53.9 LakhRevenue · FY 2025 · -24% YoY
- ₹66,477Net profit · 1% margin
- ₹5.3 LakhEBITDA · 10% margin
- ₹10 LakhPaid-up capital
- -43%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ampligene India Biotech Private Limited are on its company page.
Detailed financial statements for AmpliGene India Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AmpliGene India Biotech
AmpliGene India Biotech was founded in 2012.
AmpliGene India Biotech is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Chirag Pandya is the CEO of AmpliGene India Biotech, as recorded in our data. They have also founded this company.
The primary company behind AmpliGene India Biotech, Ampligene India Biotech Private Limited, reported revenue of ₹53.9 Lakh for FY 2025, down 24% year on year.
AmpliGene India Biotech was founded in 2012 in Ahmedabad, India, within the biotechnology sector. Isothermal nucleic acid amplification technologies are developed, focusing on portable point-of-care systems like the Genie II. These systems are applied for detecting plant pathogens and infectious diseases in animals, supporting diagnostics in agricultural and veterinary fields across relevant geographies.
AmpliGene India Biotech offers Molecular Technology Platform and GMO Testing Services.
AmpliGene India Biotech is associated with 2 legal entities: Ampligene India Biotech Private Limited, Ampligene Diagnostics Private Limited.
The legal entities of AmpliGene India Biotech currently have 3 directors, including Nirupama Ramkrishna Pandya, Deepal Pandya, Chirag Ramkrishna Pandya.